Concepedia

Jerry Y. Hsu

JY

Statistics

Publications

22

Citations

2.2K

H-Index

19

Active since

2001

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Dana-Farber Cancer Institute

Vall d'Hebron Institute of Oncology

Massachusetts General Hospital

Stanford University

Jerry Y. Hsu is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

2001–2021

22

Publications

22

Emi1 Is a Mitotic Regulator that Interacts with Cdc20 and Inhibits the Anaphase Promoting Complex

Julie D.R. Reimann, Ellen Freed, Jerry Y. Hsu et al. · Cell · 2001 · 393 citations · Full text

, , +9

E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APCCdh1

Jerry Y. Hsu, Julie D.R. Reimann, Claus Storgaard Sørensen et al. · Nature Cell Biology · 2002 · 351 citations

, , +4

Prophase Destruction of Emi1 by the SCFβTrCP/Slimb Ubiquitin Ligase Activates the Anaphase Promoting Complex to Allow Progression beyond Prometaphase

Florence Margottin-Goguet, Jerry Y. Hsu, Alexander V. Loktev et al. · Developmental Cell · 2003 · 335 citations · Full text

, , +12

Phase III randomized study of taselisib or placebo with fulvestrant in estrogen receptor-positive, PIK3CA-mutant, HER2-negative, advanced breast cancer: the SANDPIPER trial

Susan Dent, Javier Cortés, Young‐Hyuck Im et al. · Annals of Oncology · 2020 · 163 citations · Full text

, , +15

Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors

Dejan Juric, Ian E. Krop, Ramesh K. Ramanathan et al. · Cancer Discovery · 2017 · 160 citations

, , +15

1–5 of 22